Displaying 26–50 of 10975 results for

Sort By Relevance Sort By Date
1 2 3 4 5 ...439

Kids develop “werewolf syndrome” after being given mislabeled medicine

(News)

At least 17 children in Spain developed a form of “werewolf syndrome” after they were given mislabeled medication.

FDA widens generic drug recall probe beyond heart meds

(News)

The FDA is reportedly expanding its investigation related into impurities found in a class of blood pressure medications.

Report: Purdue looking to reach massive opioid settlement

(News)

With about 2,000 opioid-related lawsuits looming around the country, Purdue Pharma is reportedly offering to settle for $10-12 billion.

Oklahoma judge rules against J&J in landmark trial

(News)

A judge in Oklahoma has ordered Johnson & Johnson to pay $572 million in damages for its role in the opioid epidemic.

Blockbuster-bound Lilly drug wins another FDA nod

(News)

Eli Lilly’s Taltz has been given the go-ahead for a new indication, which could help propel the drug to blockbuster status.

Boehringer pharma head to step down

(News)

Allan Hillgrove, the board member responsible for the company's human pharma and biopharma business, is set to retire at the end of the year as the rest of the Boehringer Ingelheim board is getting shaken up..

FDA fast tracks AstraZeneca diabetes drug

(News)

Farxiga is being given a speedy review as a method to prevent heart and kidney failure in patients with chronic kidney disease.

Amgen to buy Celgene’s Otezla for $13.4B

(News)

Amgen has agreed to buy Celgene’s psoriasis treatment for $13.4 billion in cash, in a deal that will pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene.

FibroGen CEO passes away unexpectedly

(News)

Pfizer gets priority review for cancer drug label expansion

(News)

Pfizer and partner Astellas announced that the FDA has accepted the supplemental New Drug Application looking for label expansion of cancer drug, Xtandi and granted priority review designation.

Pharma in review: trending stories 8/23/19

(News)

pharma manufacturing news in review

New tuberculosis vax could improve protection

(News)

Australian researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis.

BIO 2019: It starts with one

(Article)

BIO 2019 shows how incremental investments make a global impact

Today's solid dose drugs: High potency, high stakes

(Article)

Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms

AZ drug combo misses the mark in late-stage lung cancer study

(News)

An AstraZeneca immunotherapy has failed to meet its goal in a late-stage study involving patients with advanced non-small cell lung cancer.

Pfizer makes $500M play in gene therapy market

(News)

Pfizer is injecting $500 million into a manufacturing facility in Sanford, North Carolina to position itself as a bigger player in the gene therapy market.

FDA warns Chinese company for drug manufacturing data integrity violations

(News)

The organization sent Ningbo Huize Commodity a warning letter for significant current good manufacturing practice violations, including data integrity issues.

Endo and Allergan settle major opiod case for $15 million

(News)

The agreement comes ahead of the trial scheduled for October 21, where Purdue, Teva and Johnson & Johnson are still set to face trial.

Product Focus: Optimizing your ebb and flow

(Article)

New approaches to fluid control enhance pharma manufacturing

AbbVie’s Humira follow-up gets FDA nod

(News)

A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA.

Celgene wins key FDA ok ahead of BMS merger

(News)

The U.S. FDA has approved Celgene's rare bone marrow cancer drug, Inrebic, giving the drugmaker a big regulatory win ahead of its proposed merger with Bristol-Myers Squibb.

FDA rejects potential jet lag treatment

(News)

Vanda Pharmaceuticals announced that it has received a complete response letter from the FDA for its potential treatment for jet lag.

Ebola spreads to remote Congo territory

(News)

Authorities in the Democratic Republic of Congo have confirmed a new case of Ebola in the remote, militia-controlled territory of Walikale

Pfizer recalls migraine drug for possible microbial contamination

(News)

Pfizer has recalled two lots of migraine drug Relpax after finding those lots “may not meet Pfizer’s in-house microbiological specification for the potential presence” of two kinds of bacteria.

Pharma innovation: Depends how you slice it

(Article)

The definition of pharma innovation isn’t always clear cut

Sort By Relevance Sort By Date
1 2 3 4 5 ...439